Financial results - NEURODIAB NĂSTASE S.R.L.

Financial Summary - Neurodiab Năstase S.r.l.
Unique identification code: 41400381
Registration number: J39/811/2019
Nace: 8622
Sales - Ron
68.980
Net Profit - Ron
35.724
Employee
1
The most important financial indicators for the company Neurodiab Năstase S.r.l. - Unique Identification Number 41400381: sales in 2023 was 68.980 euro, registering a net profit of 35.724 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Neurodiab Năstase S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - 19.926 56.803 55.123 63.714 68.980
Total Income - EUR - - - - - 19.926 56.803 55.183 63.716 69.924
Total Expenses - EUR - - - - - 7.100 18.121 25.092 24.567 33.501
Gross Profit/Loss - EUR - - - - - 12.827 38.682 30.091 39.148 36.423
Net Profit/Loss - EUR - - - - - 12.229 37.068 28.436 37.237 35.724
Employees - - - - - 0 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 8.6%, from 63.714 euro in the year 2022, to 68.980 euro in 2023. The Net Profit decreased by -1.400 euro, from 37.237 euro in 2022, to 35.724 in the last year.

Check the financial reports for the company - Neurodiab Năstase S.r.l.

Rating financiar

Financial Rating -
Neurodiab Năstase S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Neurodiab Năstase S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurodiab Năstase S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurodiab Năstase S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurodiab Năstase S.r.l. - CUI 41400381

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - 42.123 48.105 36.043 24.518 13.305
Current Assets - - - - - 9.876 18.899 14.262 13.601 23.831
Inventories - - - - - 0 868 0 0 0
Receivables - - - - - 217 424 530 13 1.691
Cash - - - - - 9.659 17.607 13.733 13.588 22.139
Shareholders Funds - - - - - 12.271 49.106 49.854 37.416 35.764
Social Capital - - - - - 42 41 40 41 40
Debts - - - - - 39.729 17.898 451 703 1.372
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 23.831 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.691 euro and cash availability of 22.139 euro.
The company's Equity was valued at 35.764 euro, while total Liabilities amounted to 1.372 euro. Equity decreased by -1.538 euro, from 37.416 euro in 2022, to 35.764 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Neurodiab Năstase S.r.l.

Comments - Neurodiab Năstase S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.